221 related articles for article (PubMed ID: 31209889)
1. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.
Pardini B; Corrado A; Paolicchi E; Cugliari G; Berndt SI; Bezieau S; Bien SA; Brenner H; Caan BJ; Campbell PT; Casey G; Chan AT; Chang-Claude J; Cotterchio M; Gala M; Gallinger SJ; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hsu L; Huyghe J; Jenkins MA; Le Marchand L; Lin Y; Lindor NM; Nan H; Newcomb PA; Ogino S; Potter JD; Schoen RE; Slattery ML; White E; Vodickova L; Vymetalkova V; Vodicka P; Gemignani F; Peters U; Naccarati A; Landi S
Int J Cancer; 2020 Jan; 146(2):363-372. PubMed ID: 31209889
[TBL] [Abstract][Full Text] [Related]
2. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.
Win AK; Parry S; Parry B; Kalady MF; Macrae FA; Ahnen DJ; Young GP; Lipton L; Winship I; Boussioutas A; Young JP; Buchanan DD; Arnold J; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Ann Surg Oncol; 2013 Jun; 20(6):1829-36. PubMed ID: 23358792
[TBL] [Abstract][Full Text] [Related]
3. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients.
Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM
Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834
[TBL] [Abstract][Full Text] [Related]
5. Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.
Silva P; Albuquerque C; Lage P; Fontes V; Fonseca R; Vitoriano I; Filipe B; Rodrigues P; Moita S; Ferreira S; Sousa R; Claro I; Nobre Leitão C; Chaves P; Dias Pereira A
Int J Mol Med; 2016 Sep; 38(3):687-702. PubMed ID: 27430658
[TBL] [Abstract][Full Text] [Related]
6. MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
Park JH; Kim NS; Park JY; Chae YS; Kim JG; Sohn SK; Moon JH; Kang BW; Ryoo HM; Bae SH; Choi GS; Jun SH
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1135-42. PubMed ID: 20091185
[TBL] [Abstract][Full Text] [Related]
7. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C; Damiola F; Moissonnier M; Durand G; Malakhova I; Masyakin V; Le Calvez-Kelm F; Cardis E; Byrnes G; Kesminiene A; Lesueur F
BMC Cancer; 2017 May; 17(1):328. PubMed ID: 28499365
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.
Zhang Z; Wang L; Wei S; Liu Z; Wang LE; Sturgis EM; Wei Q
DNA Repair (Amst); 2010 May; 9(5):558-66. PubMed ID: 20206583
[TBL] [Abstract][Full Text] [Related]
9. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
[TBL] [Abstract][Full Text] [Related]
10. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
[TBL] [Abstract][Full Text] [Related]
11. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
12. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China.
Zhang M; Huang WY; Andreotti G; Gao YT; Rashid A; Chen J; Sakoda LC; Shen MC; Wang BS; Chanock S; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2123-7. PubMed ID: 18708406
[TBL] [Abstract][Full Text] [Related]
13. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.
Hawkins NJ; Lee JH; Wong JJ; Kwok CT; Ward RL; Hitchins MP
Mod Pathol; 2009 Dec; 22(12):1588-99. PubMed ID: 19734844
[TBL] [Abstract][Full Text] [Related]
14. Association and interactions between DNA repair gene polymorphisms and adult glioma.
Liu Y; Scheurer ME; El-Zein R; Cao Y; Do KA; Gilbert M; Aldape KD; Wei Q; Etzel C; Bondy ML
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):204-14. PubMed ID: 19124499
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.
Barontini J; Antinucci M; Tofanelli S; Cammalleri M; Dal Monte M; Gemignani F; Vodicka P; Marangoni R; Vodickova L; Kupcinskas J; Vymetalkova V; Forsti A; Canzian F; Stein A; Moreno V; Mastrodonato N; Tavano F; Panza A; Barale R; Landi S; Campa D
BMC Gastroenterol; 2017 Sep; 17(1):104. PubMed ID: 28915899
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.
Campbell PT; Curtin K; Ulrich CM; Samowitz WS; Bigler J; Velicer CM; Caan B; Potter JD; Slattery ML
Gut; 2009 May; 58(5):661-7. PubMed ID: 18523027
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
18. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression.
Oliver JA; Ortiz R; Jimenez-Luna C; Cabeza L; Perazzoli G; Caba O; Mesas C; Melguizo C; Prados J
J Biosci; 2020; 45():. PubMed ID: 33097678
[TBL] [Abstract][Full Text] [Related]
19. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
